Biocon share price jumped over 4% to a fresh 52-week high on Thursday after reports stated that the company was evaluating an internal merger of its biosimilars arm, Biocon Biologics, with the parent ...

Biocon, the Bangalore-based biotech company, launched a novel biologic Alzumab (itolizumab) for chronic plaque psoriasis onto the Indian market this summer, riding a wave of high expectations. “It is ...

HYDERABAD, Jan 30 (Reuters) - Indian biopharma company Biocon (BION.NS), opens new tab reported third-quarter revenue on Thursday that fell about 3% when compared with the year-earlier period, which ...